Marketing Edge Pharma Limited - Limited company - abbreviated - 11.0.0

Abbreviated Accounts for the Year Ended 30 April 2014

for

Marketing Edge Pharma Limited

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

4

Chartered Certified Accountants' Report

6

DIRECTORS:

M R Coleman

Mrs A M Coleman

SECRETARY:

Mrs A M Coleman

REGISTERED OFFICE:

Old Well House

Easteds Lane

Southwater

Horsham

West Sussex

RH13 9DP

REGISTERED NUMBER:

05791849 (England and Wales)

ACCOUNTANTS:

CSL Partnership Limited

Chartered Certified Accountants

39 Chobham Road

Woking

Surrey

GU21 6JD

FIXED ASSETS

Tangible assets

2

15,617

29,898

Investments

3

8,842

8,842

24,459

38,740

CURRENT ASSETS

Debtors

13,046

23,438

Prepayments and accrued income

-

1,239

Cash at bank

22,561

21,104

35,607

45,781

CREDITORS

Amounts falling due within one year

36,793

37,053

NET CURRENT (LIABILITIES)/ASSETS

(1,186

)

8,728

TOTAL ASSETS LESS CURRENT LIABILITIES

23,273

47,468

PROVISIONS FOR LIABILITIES

3,123

5,909

NET ASSETS

20,150

41,559

CAPITAL AND RESERVES

Called up share capital

4

100

100

Profit and loss account

20,050

41,459

SHAREHOLDERS' FUNDS

20,150

41,559

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 11 July 2014 and were signed on its behalf by:

M R Coleman - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance

with the Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Motor vehicles

-

25% on reducing balance

Computer equipment

-

25% on cost

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at

the balance sheet date.

Pension costs and other post-retirement benefits

2.	TANGIBLE FIXED ASSETS

Total

£

COST

At 1 May 2013

55,047

Additions

1,669

Disposals

(24,250

)

At 30 April 2014

32,466

DEPRECIATION

At 1 May 2013

25,149

Charge for year

5,719

Eliminated on disposal

(14,019

)

At 30 April 2014

16,849

NET BOOK VALUE

At 30 April 2014

15,617

At 30 April 2013

29,898

3.	FIXED ASSET INVESTMENTS

Investments

other

than

loans

£

COST

At 1 May 2013

and 30 April 2014

8,842

NET BOOK VALUE

At 30 April 2014

8,842

At 30 April 2013

8,842

4.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2014

2013

value:

£

£

100

ordinary

£1

100

100

The following reproduces the text of the report prepared for the directors in respect of the company's annual

unaudited financial statements, from which the unaudited abbreviated accounts (set out on pages two to five)

have been prepared.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval

the financial statements of Marketing Edge Pharma Limited for the year ended 30 April 2014 which comprise

the Profit and Loss Account, the Balance Sheet, and the related notes from the company's accounting

records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its

ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com.

Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified

Accountants as detailed at http://www.accaglobal.com/factsheet163.

CSL Partnership Limited

Chartered Certified Accountants

39 Chobham Road

Woking

Surrey

GU21 6JD

11 July 2014